Results From First-in-Human Phase I Study of a Novel CD19-1XX Chimeric Antigen Receptor With Calibrated Signaling in Large B-Cell Lymphoma. uri icon

authors

  • Park, Jae H
  • Nath, Karthik
  • Valtis, Yannis K
  • Lynch, Alec
  • Cathcart, Elizabeth
  • Zhang, Honglei
  • Schoder, Heiko
  • Leithner, Doris
  • Liotta, Kelly
  • Yu, Alina
  • Stocker, Kelsey
  • Palomba, M Lia
  • Li, Jia
  • Dey, Agnish
  • Sellner, Leopold
  • Singh, Reshma
  • Sundaresan, Varsha
  • Tong, Xin
  • Zhao, Faye
  • Mansilla-Soto, Jorge
  • He, Changhao
  • Meyerson, Joel
  • Perica, Karlo
  • Hosszu, Kinga
  • McAvoy, Devin
  • Wang, Xiuyan
  • Rivière, Isabelle
  • Sadelain, Michel
  • Devlin, Sean M
  • Shah, Gunjan
  • Dahi, Parastoo B
  • Richard J Lin, MD, PhD
  • Salles, Gilles
  • Scordo, Michael

publication date

  • January 30, 2025